articleTop 1% cited

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

Annals of the Rheumatic Diseases · 2008 · Vol. 68(1) · pp. 18–24

Cédric LukasRobert Landewé✉(Maastricht University Medical Centre)Joachim Sieper(Charité - Universitätsmedizin Berlin)Maxime Dougados(Hôpital Cochin)John C. Davis(University of California, San Francisco)Joseph M. Braun(Rheumazentrum Ruhrgebiet)S van der LindenDésirée van der Heijde(Leiden University Medical Center)

View via DOI Publisher page

Spondyloarthritis Studies and Treatments Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders ResearchAnkylosing spondylitisMedicineBASDAIErythrocyte sedimentation rateInternal medicineRheumatoid arthritisPhysical therapyPsoriatic arthritisCohort

MeSH terms

Back PainBlood SedimentationC-Reactive ProteinChronic DiseaseDelphi TechniqueDisability EvaluationHumansRegression AnalysisSeverity of Illness IndexSpondylitis, AnkylosingDiscriminant AnalysisPrincipal Component Analysis

Citations

1,037

FWCI

16.50

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Correlation between the ankylosing spondyloarthritis disease activity score (ASDAS) and status of HLA-B27 and its subtype associated, to assess severity of spondyloarthritis